Genetic Disorder L.P. Kkr's Net Worth

Genetic Disorder L.P. Kkr's net worth is estimated to be at least $1,483,034,649.10 as of 06/08/2025. CoreStreet's estimation of Genetic Disorder L.P. Kkr's net worth is based on their sale of stock and current holding of stock.

Genetic Disorder L.P. Kkr is Major Shareholder at KKR & Co LP. They have executed at least 10 trades of stock as per SEC Form 4 filings. Their most recent trade was for 6,000,000 units of KKR stock on 05/12/2025. Their biggest sale was on 02/17/2021 when they sold 3,450,000 units of BridgeBio Pharma Inc stock for $208,621,500.00. They typically trade 2 times per year.

Total value of insider buys:
  • $90,001,400.00
Total value of insider sells:
  • $1,393,033,249.10
Most recent insider trade:
  • May 12, 2025

Genetic Disorder L.P. Kkr's Insider Trading History

KKR & Co LPTitleAmountPriceTypeTotal Value
May 12, 2025
Major Shareholder6,000,000$34.20Sell$205,200,000.00
March 5, 2025
Major Shareholder6,000,000$32.96Sell$197,760,000.00
Sept. 13, 2024
Major Shareholder5,800,000$25.75Sell$149,350,000.00
July 1, 2019
Major Shareholder2,647,100$17.00Buy$45,000,700.00
BridgeBio Pharma IncTitleAmountPriceTypeTotal Value
May 12, 2025
Major Shareholder6,000,000$34.20Sell$205,200,000.00
March 5, 2025
Major Shareholder6,000,000$32.96Sell$197,760,000.00
Sept. 13, 2024
Major Shareholder5,800,000$25.75Sell$149,350,000.00
Feb. 17, 2021
Major Shareholder3,450,000$60.47Sell$208,621,500.00
May 28, 2020
Major Shareholder2,389,690$33.39Sell$79,791,749.10
July 1, 2019
Major Shareholder2,647,100$17.00Buy$45,000,700.00